Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Migration of hemopoietic stem cells and B lymphocytes from bone marrow to the spleen in the presence of phenylhydrazine-induced anemia. [Mice]

Journal Article · · Radiobiology (USSR) (Engl. Transl.); (United States)
OSTI ID:5705283
The effect of phenylhydrazine-induced anemia on processes of migration of polypotent hematopoietic stem cells (PHSC) and B cells from bone marrow to the spleen was studied. CBA mice were given phenylhydrazine hydrochloride 3 times at the rate of 1.2 mg/mouse on -3, -2, and 0 days. The mice develop marked anemia. The most intensive migration was observed on the first day after the last injection. On the 4th and 7th day after the last injection of phenylhydrazine, migration of PHSC exceeded the level obtained in control animals by 9 and 4 times, respectively. On the 1st and 4th days after the last injection of phenylhydrazine there was more intensive migration of B cells from bone marrow to the spleen. However, there was a sharp decrease in migration of B cells on the 7th day after the last phenylhydrazine injection. The data are apparently indicative of the fact that stimulation of erythropoiesis by means of phenylhydrazine stimulates migration of both PHSC and B cells from bone marrow to the spleen. That migration of PHSC from bone marrow is the chief mechanism of increase in content thereof in the spleen is confirmed. It may be assumed that intensification of PHSC migration is attributable to elevation of the level of endogenous erythropoietin. The data indicate that stimulation of erythropoiesis in the presence of phenylhydrazine-induced anemia leads to greater migration of cells of the nonerythropoietic population, in particular, B lymphocytes. It may also be assumed that, in the presence of erythroid hyperplasia, cells referable to other classes of hemopoiesis are ejected from bone marrow, including the precursors of immunocompetent cells B lymphocytes, which then settle in the spleen. However, the possibility of a direct effect of erythropoietin on B cells cannot be ruled out. (ERB)
Research Organization:
Inst. of Clinical and Experimental Medicine, Novosibirsk, USSR
OSTI ID:
5705283
Journal Information:
Radiobiology (USSR) (Engl. Transl.); (United States), Journal Name: Radiobiology (USSR) (Engl. Transl.); (United States) Vol. 18:2; ISSN RADBA
Country of Publication:
United States
Language:
English